The early detection and treatment of persons at-risk for psychosis is currently regarded a promising strategy in fighting the devastating consequences of psychotic disorders. The two current at-risk approaches, i.e., the “ultra high risk” and the “basic symptom” criteria, were mainly developed on adult samples. Initial evidence suggests, however, that they cannot simply be applied to children and adolescents. For ultra high risk criteria, there is indication of some attenuated psychotic symptoms being potentially non-specific in adolescents and of brief limited intermittent symptoms being difficult to clinically classify in children when observable behavioral correlates are missing. For basic symptoms, too, only preliminary indication of their usefulness in children and adolescents exists. Since developmental peculiarities in the assessment of basic symptoms should be considered, a child and youth version of the Schizophrenia Proneness Instrument (SPI-CY) was developed. In conclusion, research on the clinical-prognostic validity of the at-risk criteria and their potential adaption to the special needs of children and adolescents is needed. If a Prodromal Risk Syndrome for Psychosis or Attenuated Psychotic Symptoms Syndrome will be included into DSM-V, it has to be highlighted that its suitability for children and adolescents is only insufficiently known.

Le sfide per una corretta individuazione precoce delle psicosi nei bambini e negli adolescenti / FIORI NASTRO, Paolo; B. G., Schimmelmann; E., Gebhardt; Monducci, Elena; F., Resch; E., Koch; F., Schultze Lutter. - In: RIVISTA DI PSICHIATRIA. - ISSN 0035-6484. - STAMPA. - 47:2(2012), pp. 116-125. [10.1708/1069.11716]

Le sfide per una corretta individuazione precoce delle psicosi nei bambini e negli adolescenti

FIORI NASTRO, Paolo;MONDUCCI, ELENA;
2012

Abstract

The early detection and treatment of persons at-risk for psychosis is currently regarded a promising strategy in fighting the devastating consequences of psychotic disorders. The two current at-risk approaches, i.e., the “ultra high risk” and the “basic symptom” criteria, were mainly developed on adult samples. Initial evidence suggests, however, that they cannot simply be applied to children and adolescents. For ultra high risk criteria, there is indication of some attenuated psychotic symptoms being potentially non-specific in adolescents and of brief limited intermittent symptoms being difficult to clinically classify in children when observable behavioral correlates are missing. For basic symptoms, too, only preliminary indication of their usefulness in children and adolescents exists. Since developmental peculiarities in the assessment of basic symptoms should be considered, a child and youth version of the Schizophrenia Proneness Instrument (SPI-CY) was developed. In conclusion, research on the clinical-prognostic validity of the at-risk criteria and their potential adaption to the special needs of children and adolescents is needed. If a Prodromal Risk Syndrome for Psychosis or Attenuated Psychotic Symptoms Syndrome will be included into DSM-V, it has to be highlighted that its suitability for children and adolescents is only insufficiently known.
2012
prodromo; schizofrenia; adolescenza; diagnosi precoce; intervento precoce; psicosi.
01 Pubblicazione su rivista::01a Articolo in rivista
Le sfide per una corretta individuazione precoce delle psicosi nei bambini e negli adolescenti / FIORI NASTRO, Paolo; B. G., Schimmelmann; E., Gebhardt; Monducci, Elena; F., Resch; E., Koch; F., Schultze Lutter. - In: RIVISTA DI PSICHIATRIA. - ISSN 0035-6484. - STAMPA. - 47:2(2012), pp. 116-125. [10.1708/1069.11716]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/438760
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 5
social impact